ReP USP - Resultado da busca

Artigo de periodico
Low DICER1 expression is associated with poor clinical outcome in adrenocortical carcinoma (2015)
Sousa, Gabriela Resende Vieira de; Ribeiro, Tamaya C.; Faria, Andre M.; Mariani, Beatriz M. P.; Lerario, Antonio M.; Zerbini, Maria Claudia N.; Soares, Iberê C.; Wakamatsu, Alda; Alves, Venancio A. F.; Mendonca, Berenice B.; Fragoso, Maria Candida B. V.; Latronico, Ana Claudia; Almeida, Madson Q.
Source: Oncotarget. Unidade: FM
Subjects: ADENOCARCINOMA, NEOPLASIAS EPITELIAIS E GLANDULARES, INCIDÊNCIA, CARCINOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUSA, Gabriela Resende Vieira de et al. Low DICER1 expression is associated with poor clinical outcome in adrenocortical carcinoma. Oncotarget, v. 6, n. 26, p. 22724-22733, 2015Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.4261. Acesso em: 05 maio 2026.
APA
Sousa, G. R. V. de, Ribeiro, T. C., Faria, A. M., Mariani, B. M. P., Lerario, A. M., Zerbini, M. C. N., et al. (2015). Low DICER1 expression is associated with poor clinical outcome in adrenocortical carcinoma. Oncotarget, 6( 26), 22724-22733. doi:10.18632/oncotarget.4261
NLM
Sousa GRV de, Ribeiro TC, Faria AM, Mariani BMP, Lerario AM, Zerbini MCN, Soares IC, Wakamatsu A, Alves VAF, Mendonca BB, Fragoso MCBV, Latronico AC, Almeida MQ. Low DICER1 expression is associated with poor clinical outcome in adrenocortical carcinoma [Internet]. Oncotarget. 2015 ; 6( 26): 22724-22733.[citado 2026 maio 05 ] Available from: https://doi.org/10.18632/oncotarget.4261
Vancouver
Sousa GRV de, Ribeiro TC, Faria AM, Mariani BMP, Lerario AM, Zerbini MCN, Soares IC, Wakamatsu A, Alves VAF, Mendonca BB, Fragoso MCBV, Latronico AC, Almeida MQ. Low DICER1 expression is associated with poor clinical outcome in adrenocortical carcinoma [Internet]. Oncotarget. 2015 ; 6( 26): 22724-22733.[citado 2026 maio 05 ] Available from: https://doi.org/10.18632/oncotarget.4261
Artigo de periodico
Localization of Occult Adrenal Tissue with Cosyntropin-Stimulated 18F-FDG-PET/CT in a Patient with Metachronous Adrenocortical Tumor Who Presented with Persistently Elevated DHEAS after Bilateral Adrenalectomy (2012)
Franco, Maira R; Alencar, Guilherme A.; Faria, Andre M.; Bezerra, Evangelhista; Cruz, Carolina; Domenice, Sorahia; Lima, Lorena O.; Latronico, Ana C.; Mendonca, Berenice B.; Lerario, Antonio M.; Almeida, Madson Q.; Fragoso, Maria Candida B. V.
Source: Endocrine Reviews. Conference titles: ENDO 2012: The Endocrine Society's 94th Annual Meeting & Expo. Unidade: FM
Subjects: PUBERDADE PRECOCE, CARCINOMA, NEOPLASIAS DAS GLÂNDULAS SUPRARRENAIS, METÁSTASE NEOPLÁSICA, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRANCO, Maira R et al. Localization of Occult Adrenal Tissue with Cosyntropin-Stimulated 18F-FDG-PET/CT in a Patient with Metachronous Adrenocortical Tumor Who Presented with Persistently Elevated DHEAS after Bilateral Adrenalectomy. Endocrine Reviews, v. 33, 2012Tradução . . Disponível em: http://edrv.endojournals.org/cgi/content/meeting_abstract/33/03_MeetingAbstracts/SAT-452. Acesso em: 05 maio 2026.
APA
Franco, M. R., Alencar, G. A., Faria, A. M., Bezerra, E., Cruz, C., Domenice, S., et al. (2012). Localization of Occult Adrenal Tissue with Cosyntropin-Stimulated 18F-FDG-PET/CT in a Patient with Metachronous Adrenocortical Tumor Who Presented with Persistently Elevated DHEAS after Bilateral Adrenalectomy. Endocrine Reviews, 33. Recuperado de http://edrv.endojournals.org/cgi/content/meeting_abstract/33/03_MeetingAbstracts/SAT-452
NLM
Franco MR, Alencar GA, Faria AM, Bezerra E, Cruz C, Domenice S, Lima LO, Latronico AC, Mendonca BB, Lerario AM, Almeida MQ, Fragoso MCBV. Localization of Occult Adrenal Tissue with Cosyntropin-Stimulated 18F-FDG-PET/CT in a Patient with Metachronous Adrenocortical Tumor Who Presented with Persistently Elevated DHEAS after Bilateral Adrenalectomy [Internet]. Endocrine Reviews. 2012 ; 33[citado 2026 maio 05 ] Available from: http://edrv.endojournals.org/cgi/content/meeting_abstract/33/03_MeetingAbstracts/SAT-452
Vancouver
Franco MR, Alencar GA, Faria AM, Bezerra E, Cruz C, Domenice S, Lima LO, Latronico AC, Mendonca BB, Lerario AM, Almeida MQ, Fragoso MCBV. Localization of Occult Adrenal Tissue with Cosyntropin-Stimulated 18F-FDG-PET/CT in a Patient with Metachronous Adrenocortical Tumor Who Presented with Persistently Elevated DHEAS after Bilateral Adrenalectomy [Internet]. Endocrine Reviews. 2012 ; 33[citado 2026 maio 05 ] Available from: http://edrv.endojournals.org/cgi/content/meeting_abstract/33/03_MeetingAbstracts/SAT-452
Artigo de periodico
Combined expression of BUB1B, DLG7, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patients (2012)
Fragoso, Maria Candida B. V.; Almeida, Madson Queiroz; Mazzuco, Tania L.; Mariani, Beatriz M. P.; Brito, Luciana P.; Gonçalves, Talita Cardoso; Alencar, Guilherme A.; Lima, Lorena de O.; Faria, Andre M.; Bourdeau, Isabelle; Lucon, Antonio M.; Freire, Daniel S.; Latronico, Ana Claudia; Mendonca, Berenice B.; Lacroix, Andre; Lerario, Antonio M.
Source: European Journal of Endocrinology. Unidade: FM
Subjects: MUTAÇÃO GENÉTICA, NEOPLASIAS DAS GLÂNDULAS SUPRARRENAIS, PROGNÓSTICO, CRIANÇAS, ADULTOS, EXPRESSÃO GÊNICA, ESTUDOS DE COORTES, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FRAGOSO, Maria Candida B. V. et al. Combined expression of BUB1B, DLG7, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patients. European Journal of Endocrinology, v. 166, n. 1, p. 61-67, 2012Tradução . . Disponível em: https://doi.org/10.1530/EJE-11-0964. Acesso em: 05 maio 2026.
APA
Fragoso, M. C. B. V., Almeida, M. Q., Mazzuco, T. L., Mariani, B. M. P., Brito, L. P., Gonçalves, T. C., et al. (2012). Combined expression of BUB1B, DLG7, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patients. European Journal of Endocrinology, 166( 1), 61-67. doi:10.1530/EJE-11-0964
NLM
Fragoso MCBV, Almeida MQ, Mazzuco TL, Mariani BMP, Brito LP, Gonçalves TC, Alencar GA, Lima L de O, Faria AM, Bourdeau I, Lucon AM, Freire DS, Latronico AC, Mendonca BB, Lacroix A, Lerario AM. Combined expression of BUB1B, DLG7, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patients [Internet]. European Journal of Endocrinology. 2012 ; 166( 1): 61-67.[citado 2026 maio 05 ] Available from: https://doi.org/10.1530/EJE-11-0964
Vancouver
Fragoso MCBV, Almeida MQ, Mazzuco TL, Mariani BMP, Brito LP, Gonçalves TC, Alencar GA, Lima L de O, Faria AM, Bourdeau I, Lucon AM, Freire DS, Latronico AC, Mendonca BB, Lacroix A, Lerario AM. Combined expression of BUB1B, DLG7, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patients [Internet]. European Journal of Endocrinology. 2012 ; 166( 1): 61-67.[citado 2026 maio 05 ] Available from: https://doi.org/10.1530/EJE-11-0964

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em